Barbara Ryan - Net Worth and Insider Trading
Barbara Ryan Net Worth
The estimated net worth of Barbara Ryan is at least $1,104 dollars as of 2024-06-19. Barbara Ryan is the Director of INVO Bioscience Inc and owns about 1,150 shares of INVO Bioscience Inc (INVO) stock worth over $1,104. Details can be seen in Barbara Ryan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barbara Ryan has not made any transactions after 2022-06-01 and currently still holds the listed stock(s).
Transaction Summary of Barbara Ryan
Barbara Ryan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barbara Ryan owns 3 companies in total, including INVO Bioscience Inc (INVO) , MiNK Therapeutics Inc (INKT) , and Azitra Inc (AZTR) .
Click here to see the complete history of Barbara Ryan’s form 4 insider trades.
Insider Ownership Summary of Barbara Ryan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INVO | INVO Bioscience Inc | 2022-06-01 | director |
| INKT | MiNK Therapeutics Inc | 2021-10-13 | director |
| AZTR | Azitra Inc | 2023-06-15 | director |
Barbara Ryan Latest Holdings Summary
Barbara Ryan currently owns a total of 1 stock. Barbara Ryan owns 1,150 shares of INVO Bioscience Inc (INVO) as of June 1, 2022, with a value of $1,104.
Latest Holdings of Barbara Ryan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INVO | INVO Bioscience Inc | 2022-06-01 | 1,150 | 0.96 | 1,104 |
Holding Weightings of Barbara Ryan
Barbara Ryan Form 4 Trading Tracker
According to the SEC Form 4 filings, Barbara Ryan has made a total of 1 transactions in INVO Bioscience Inc (INVO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in INVO Bioscience Inc is the acquisition of 526 shares on June 1, 2022, which cost Barbara Ryan around $10,000.
Insider Trading History of Barbara Ryan
- 1
Barbara Ryan Trading Performance
GuruFocus tracks the stock performance after each of Barbara Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barbara Ryan is 3.3%. GuruFocus also compares Barbara Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barbara Ryan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barbara Ryan's insider trading performs compared to the benchmark.
Performance of Barbara Ryan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.85 | | | | | |
| Relative Return to S&P 500(%) | -7.12 | | | | | |
Barbara Ryan Ownership Network
Barbara Ryan Owned Company Details
What does INVO Bioscience Inc do?
Who are the key executives at INVO Bioscience Inc?
Barbara Ryan is the director of INVO Bioscience Inc. Other key executives at INVO Bioscience Inc include Chief Financial Officer Andrea Goren , 10 percent owner Awm Investment Company, Inc. , and director & Medical Director Kevin Doody .
INVO Bioscience Inc (INVO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of INVO Bioscience Inc (INVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of INVO Bioscience Inc (INVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
INVO Bioscience Inc (INVO)'s detailed insider trading history can be found in Insider Trading Tracker table.
INVO Bioscience Inc Insider Transactions
Barbara Ryan Mailing Address
Above is the net worth, insider trading, and ownership report for Barbara Ryan. You might contact Barbara Ryan via mailing address: 22 Cavray Road, Norwalk Ct 06855.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
